<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01747369</url>
  </required_header>
  <id_info>
    <org_study_id>PneumoTone</org_study_id>
    <nct_id>NCT01747369</nct_id>
  </id_info>
  <brief_title>Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agence de Médecine Préventive, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region Sanitaire des Savanes, Togo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministere de la Sante et de la Promotion Sociale, Togo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National d'Hygiene, Togo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Muraz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation Mérieux, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Agence de Médecine Préventive, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to estimate the burden of disease due to pneumococci, other bacteria
      and viruses in the African meningitis belt prior to pneumococcal conjugate vaccine
      introduction and to estimate the population impact of the vaccine after its implementation in
      2014. In a defined population of a sanitary district in northern Togo, during the period 2010
      to 2017, investigators enroll patients of all ages with suspected pneumonia requiring
      hospitalization or suspected bacterial meningitis. Patients are evaluated by bacteriology and
      molecular biology techniques on blood, cerebro-spinal fluid, nasal aspirates and by chest
      X-ray.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2010</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of pneumococcal pneumonia requiring hospitalisation, confirmed by blood culture or PCR analysis of blood</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of pneumococcal meningitis, confirmed by culture or PCR on cerebro-spinal fluid</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of radiologically confirmed pneumonia requiring hospitalisation</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of suspected pneumonia requiring hospitalisation with elevated C-reactive protein serum concentration (&lt;40mg/l)</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of suspected pneumonia requiring hospitalisation with reduced oxygen saturation (&lt;90%)</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pneumonia of other bacterial or viral etiology requiring hospitalisation</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of acute meningitis of other bacterial etiology</measure>
    <time_frame>Subjects will be enrolled on admission to hospital and followed for the duration of hospitalization (median duration 6 days)</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Pneumonia, Bacterial</condition>
  <condition>Pneumonia, Viral</condition>
  <condition>Meningitis, Bacterial</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, cerebro-spinal fluid, nasal aspirate
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pneumonia surveillance:

        -residents of Tône sanitary district requiring hospitaliation for suspected pneumonia and
        presenting at one of the hospitals of Dapaong town (district capital)

        Meningitis surveillance:

        - residents fo Tône sanitary district presenting with suspected meningitis at one of the
        hospitals of Dapaong town (district capital) or Sinkasse health center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Pneumonia surveillance:

        Inclusion Criteria:

          -  resident of Tône sanitary district - requiring hospitalisation for at least one night
             for clinical pneumonia syndrome

          -  hospitalised in a study site during the study period

        Exclusion Criteria:

          -  absence of informed consent by patient or legal tutor

        Meningitis surveillance:

        Inclusion Criteria:

          -  resident of Tône sanitary district

          -  presenting clinical signs of acute bacterial meningitis

          -  hospitalised in a study site during the study period

        Exclusion Criteria:

          -  absence of informed consent by patient or legal tutor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer C Moïsi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Agence de Médecine Préventive</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Makawa-Sy Makawa, MD</last_name>
    <phone>+228-921 29 31</phone>
    <email>makmaksy@yahoo.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haoua Tall, PharmD MPH</last_name>
    <phone>+226-50300406</phone>
    <email>htall@aamp.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre médico-social (CMS)</name>
      <address>
        <city>Cinkassé</city>
        <state>Savanes region</state>
        <country>Togo</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional (CHR) Savanes</name>
      <address>
        <city>Dapaong</city>
        <state>Savanes region</state>
        <country>Togo</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Win' Pang</name>
      <address>
        <city>Dapaong</city>
        <state>Savanes region</state>
        <country>Togo</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital d'enfants Yendubé</name>
      <address>
        <city>Dapaong</city>
        <state>Savanes region</state>
        <country>Togo</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique</name>
      <address>
        <city>Dapaong</city>
        <state>Savanes region</state>
        <country>Togo</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Togo</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2011</study_first_submitted>
  <study_first_submitted_qc>December 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2012</study_first_posted>
  <last_update_submitted>March 3, 2017</last_update_submitted>
  <last_update_submitted_qc>March 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surveillance study</keyword>
  <keyword>prospective</keyword>
  <keyword>observational</keyword>
  <keyword>health center-based</keyword>
  <keyword>pneumonia, bacterial</keyword>
  <keyword>pneumonia, viral</keyword>
  <keyword>meningitis, bacterial</keyword>
  <keyword>Africa south of the Sahara</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Pneumonia, Bacterial</mesh_term>
    <mesh_term>Meningitis, Bacterial</mesh_term>
    <mesh_term>Pneumonia, Viral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

